+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Irritable Bowel Syndrome"

From
From
Constipation Treatment Global Market Report 2024 - Product Thumbnail Image

Constipation Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2024 - Product Thumbnail Image

Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Constipation Treatment - Global Strategic Business Report - Product Thumbnail Image

Constipation Treatment - Global Strategic Business Report

  • Report
  • May 2024
  • 194 Pages
  • Global
From
Intussusception Global Market Report 2024 - Product Thumbnail Image

Intussusception Global Market Report 2024

  • Report
  • March 2024
  • 175 Pages
  • Global
From
Viral Gastroenteritis Global Market Report 2024 - Product Thumbnail Image

Viral Gastroenteritis Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
Irritable Bowel Syndrome (IBS) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Irritable Bowel Syndrome (IBS) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
From
Market Spotlight: Irritable Bowel Syndrome (IBS) (2020) - Product Thumbnail Image

Market Spotlight: Irritable Bowel Syndrome (IBS) (2020)

  • Report
  • March 2020
  • 49 Pages
  • Global
Loading Indicator

The Irritable Bowel Syndrome (IBS) market is a subset of the Gastroenterology market. IBS is a chronic disorder of the digestive system that affects the large intestine. Symptoms include abdominal pain, bloating, constipation, and diarrhea. Treatment options include dietary changes, medications, and lifestyle modifications. The IBS market is expected to grow due to increasing prevalence of the disorder, rising awareness of IBS, and the availability of new treatments. Additionally, the increasing demand for better diagnosis and treatment of IBS is expected to drive the market. Some companies in the IBS market include Allergan, AstraZeneca, GlaxoSmithKline, Ironwood Pharmaceuticals, Novartis, Pfizer, Salix Pharmaceuticals, Shire, Sucampo Pharmaceuticals, and Takeda Pharmaceuticals. Show Less Read more